Advanced Therapeutic Solutions, LLC
Advanced Therapeutic Solutions, LLC

Advanced Therapeutic Solutions, LLC To Distribute ReLuma

West Palm Beach, FL, August 02, 2005 --(PR.com)-- Advanced Therapeutic Solutions, LLC. (ATS) has signed a distribution agreement with Invitrx Inc. for ReLuma™, a non-invasive product for aging and sun-damaged skin. ReLuma will be marketed to physicians by ATS sales professionals throughout the United States. ReLuma is the only skincare product containing patent-pending technology for the delivery of nine key growth factors found in natural human skin and is the first tissue-engineered product from the emerging biotech company Invitrx. Together, the human growth factors, cytokines and interleukins in ReLuma have been clinically shown to help diminish the visible signs of aging, such as wrinkles, fine lines and uneven skin texture.

ReLuma is the result of Invitrx’s innovative process for growing bioengineered human tissue for treating chronic wounds and burns. As the tissue grows, it produces an array of natural growth factors and other elements important to healthy skin that are harvested to make ReLuma. These natural human growth factors include TGF-b (1-3) [Transforming growth factor beta], PDGF [Platelet derived growth factor], GM-CSF [Granulocyte-macrophage colony-stimulating factor], and Interleukins (IL3, IL6-8). As we age, the production of these growth factors within skin is reduced, and leads to wrinkling and thinning of the skin. By re-introducing these factors through daily application of ReLuma, damaged skin cells are repaired, and skin tissue regenerated. The appearance of fine lines and wrinkles is diminished, and smoother, more luminous skin results.

Patients from an ongoing clinical study had the following results after only 4 weeks of ReLuma use:
88% saw improvement in overall appearance of their skin
75% experienced improvement in skin texture/smoothness
70% felt an increase in skin firmness and elasticity
70% saw a reduction in the appearance of fine lines and wrinkles.

Unlike ReLuma, many topical skincare products available to physicians today cause some degree of irritation and photosensitivity among patients. ReLuma works through growth stimulation, not exfoliation. In addition to its use in anti-aging, rosacea and discoloration protocols, ReLuma may be used as wound care post laser resurfacing, IPL, Erbium Yag and chemical peel. ReLuma is available for sale by physicians through their practices or medically supervised spas. For more information on ReLuma, please call an Advanced Therapeutic Solutions representative at 1-877-287-6376 or visit www.flmesoderm.com.

About Advanced Therapeutic Solutions
Advanced Therapeutic Solutions is a privately held limited liability company organized under the laws of the State of Florida and registered with Dun and Bradstreet. It is a dynamic specialty medical distribution company focused on providing its clients with access to exceptional medical sales professionals. The company’s particular expertise is the business of medical aesthetics and skin therapeutics.

About Invitrx, Inc.
Invitrx, Inc. is a biotechnology company specializing in tissue engineering solutions and developing innovative products for wound closure, corneal transplants, and alternative testing. ReLuma is one result of Invitrx’s innovation in tissue engineering and is part of the product portfolio of its subsidiary Invitrx Cosmeceuticals.

###

Contact: Shawn Rhodes, Advanced Therapeutic Solutions, 561-963-4700 or srhodes@flmesoderm.com
Contact
Advanced Therapeutic Solutions, LLC
Shawn Rhodes
561-963-4700
www.flmesoderm.com
ContactContact